Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study.
Navarro J, González-Cordón A, Casado JL, Bernardino JI, Domingo P, Portilla J, Llibre JM, Colomer J, Rial-Crestelo D, Vizcarra P, Curran A, Martínez E, Ribera E.
Navarro J, et al. Among authors: vizcarra p.
J Antimicrob Chemother. 2020 Jul 1;75(7):1955-1960. doi: 10.1093/jac/dkaa072.
J Antimicrob Chemother. 2020.
PMID: 32134108